Clinical significance of ASB9 in human colorectal cancer

Masayoshi Tokuoka, Norikatsu Miyoshi, Toshiki Hitora, Koshi Mimori, Fumiaki Tanaka, Koichi Shibata, Hideshi Ishii, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Ankyrin repeat and SOCS box-containing 9 (ASB9) is involved in the negative regulation of cytokine signaling. However, its biological function is largely undefined. The aim of this study was to assess the value and role of ASB9 as an indicator of prognosis in colorectal cancer (CRC). In order to demonstrate the importance of ASB9 expression for predicting the prognosis of CRC, we analyzed the ASB9 mRNA expression in 125 paired cases of CRC and non-cancerous regions and the protein expression by immunohistochemistry. To investigate the role of ASB9 in vitro, we performed proliferation and invasion assay with small interfering RNA against ASB9. ASB9 mRNA expression was higher in CRC tissue than corresponding normal tissue (P=0.0282). Patients expressing low levels of ASB9 had a poorer overall survival rate than those expressing high levels (P=0.0301), indicating that decreased ASB9 expression was an independent prognostic factor. The immunohistochemical study revealed that ASB9 was predominantly expressed in cancer cells. A multivariate analysis showed that ASB9 expression status was an independent prognostic factor of overall survival (relative risk, 4.09; 95% confidence interval, 1.47-11.88; P=0.007). In an invasion assay, ASB9 siRNA-transfected cells showed significantly high invasiveness. The results of the present study suggest that ASB9 is a useful prognostic marker for CRC.

Original languageEnglish
Pages (from-to)1105-1111
Number of pages7
JournalInternational Journal of Oncology
Volume37
Issue number5
DOIs
Publication statusPublished - Nov 1 2010

Fingerprint

Colorectal Neoplasms
Small Interfering RNA
Ankyrin Repeat
Messenger RNA
Multivariate Analysis
Survival Rate
Immunohistochemistry
Confidence Intervals
Cytokines
Survival
Neoplasms
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Clinical significance of ASB9 in human colorectal cancer. / Tokuoka, Masayoshi; Miyoshi, Norikatsu; Hitora, Toshiki; Mimori, Koshi; Tanaka, Fumiaki; Shibata, Koichi; Ishii, Hideshi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki.

In: International Journal of Oncology, Vol. 37, No. 5, 01.11.2010, p. 1105-1111.

Research output: Contribution to journalArticle

Tokuoka, M, Miyoshi, N, Hitora, T, Mimori, K, Tanaka, F, Shibata, K, Ishii, H, Sekimoto, M, Doki, Y & Mori, M 2010, 'Clinical significance of ASB9 in human colorectal cancer', International Journal of Oncology, vol. 37, no. 5, pp. 1105-1111. https://doi.org/10.3892/ijo-00000762
Tokuoka M, Miyoshi N, Hitora T, Mimori K, Tanaka F, Shibata K et al. Clinical significance of ASB9 in human colorectal cancer. International Journal of Oncology. 2010 Nov 1;37(5):1105-1111. https://doi.org/10.3892/ijo-00000762
Tokuoka, Masayoshi ; Miyoshi, Norikatsu ; Hitora, Toshiki ; Mimori, Koshi ; Tanaka, Fumiaki ; Shibata, Koichi ; Ishii, Hideshi ; Sekimoto, Mitsugu ; Doki, Yuichiro ; Mori, Masaki. / Clinical significance of ASB9 in human colorectal cancer. In: International Journal of Oncology. 2010 ; Vol. 37, No. 5. pp. 1105-1111.
@article{b4f61839a3c141fb81b13afe37fc6878,
title = "Clinical significance of ASB9 in human colorectal cancer",
abstract = "Ankyrin repeat and SOCS box-containing 9 (ASB9) is involved in the negative regulation of cytokine signaling. However, its biological function is largely undefined. The aim of this study was to assess the value and role of ASB9 as an indicator of prognosis in colorectal cancer (CRC). In order to demonstrate the importance of ASB9 expression for predicting the prognosis of CRC, we analyzed the ASB9 mRNA expression in 125 paired cases of CRC and non-cancerous regions and the protein expression by immunohistochemistry. To investigate the role of ASB9 in vitro, we performed proliferation and invasion assay with small interfering RNA against ASB9. ASB9 mRNA expression was higher in CRC tissue than corresponding normal tissue (P=0.0282). Patients expressing low levels of ASB9 had a poorer overall survival rate than those expressing high levels (P=0.0301), indicating that decreased ASB9 expression was an independent prognostic factor. The immunohistochemical study revealed that ASB9 was predominantly expressed in cancer cells. A multivariate analysis showed that ASB9 expression status was an independent prognostic factor of overall survival (relative risk, 4.09; 95{\%} confidence interval, 1.47-11.88; P=0.007). In an invasion assay, ASB9 siRNA-transfected cells showed significantly high invasiveness. The results of the present study suggest that ASB9 is a useful prognostic marker for CRC.",
author = "Masayoshi Tokuoka and Norikatsu Miyoshi and Toshiki Hitora and Koshi Mimori and Fumiaki Tanaka and Koichi Shibata and Hideshi Ishii and Mitsugu Sekimoto and Yuichiro Doki and Masaki Mori",
year = "2010",
month = "11",
day = "1",
doi = "10.3892/ijo-00000762",
language = "English",
volume = "37",
pages = "1105--1111",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Clinical significance of ASB9 in human colorectal cancer

AU - Tokuoka, Masayoshi

AU - Miyoshi, Norikatsu

AU - Hitora, Toshiki

AU - Mimori, Koshi

AU - Tanaka, Fumiaki

AU - Shibata, Koichi

AU - Ishii, Hideshi

AU - Sekimoto, Mitsugu

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Ankyrin repeat and SOCS box-containing 9 (ASB9) is involved in the negative regulation of cytokine signaling. However, its biological function is largely undefined. The aim of this study was to assess the value and role of ASB9 as an indicator of prognosis in colorectal cancer (CRC). In order to demonstrate the importance of ASB9 expression for predicting the prognosis of CRC, we analyzed the ASB9 mRNA expression in 125 paired cases of CRC and non-cancerous regions and the protein expression by immunohistochemistry. To investigate the role of ASB9 in vitro, we performed proliferation and invasion assay with small interfering RNA against ASB9. ASB9 mRNA expression was higher in CRC tissue than corresponding normal tissue (P=0.0282). Patients expressing low levels of ASB9 had a poorer overall survival rate than those expressing high levels (P=0.0301), indicating that decreased ASB9 expression was an independent prognostic factor. The immunohistochemical study revealed that ASB9 was predominantly expressed in cancer cells. A multivariate analysis showed that ASB9 expression status was an independent prognostic factor of overall survival (relative risk, 4.09; 95% confidence interval, 1.47-11.88; P=0.007). In an invasion assay, ASB9 siRNA-transfected cells showed significantly high invasiveness. The results of the present study suggest that ASB9 is a useful prognostic marker for CRC.

AB - Ankyrin repeat and SOCS box-containing 9 (ASB9) is involved in the negative regulation of cytokine signaling. However, its biological function is largely undefined. The aim of this study was to assess the value and role of ASB9 as an indicator of prognosis in colorectal cancer (CRC). In order to demonstrate the importance of ASB9 expression for predicting the prognosis of CRC, we analyzed the ASB9 mRNA expression in 125 paired cases of CRC and non-cancerous regions and the protein expression by immunohistochemistry. To investigate the role of ASB9 in vitro, we performed proliferation and invasion assay with small interfering RNA against ASB9. ASB9 mRNA expression was higher in CRC tissue than corresponding normal tissue (P=0.0282). Patients expressing low levels of ASB9 had a poorer overall survival rate than those expressing high levels (P=0.0301), indicating that decreased ASB9 expression was an independent prognostic factor. The immunohistochemical study revealed that ASB9 was predominantly expressed in cancer cells. A multivariate analysis showed that ASB9 expression status was an independent prognostic factor of overall survival (relative risk, 4.09; 95% confidence interval, 1.47-11.88; P=0.007). In an invasion assay, ASB9 siRNA-transfected cells showed significantly high invasiveness. The results of the present study suggest that ASB9 is a useful prognostic marker for CRC.

UR - http://www.scopus.com/inward/record.url?scp=77957878316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957878316&partnerID=8YFLogxK

U2 - 10.3892/ijo-00000762

DO - 10.3892/ijo-00000762

M3 - Article

C2 - 20878058

AN - SCOPUS:77957878316

VL - 37

SP - 1105

EP - 1111

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -